Effects of a selective aldosterone blocker and thiazide-type diuretic on blood pressure and organ damage in hypertensive patients

References

• Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res 2014;37:286–90
   Web of Science ®Google Scholar
• The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC): 2013 ESH/ESC Guidelines for the management of arterial hypertension. J Hypertens 2013;31:1281–357
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare. National Health and Nutrition Survey Japan 2013. Tokyo: Ministry of Health, Health, Labour and Welfare; 2013 (in Japanese)
   Google Scholar
• Ohta Y, Tsuchihashi T, Onaka U, et al. Long-term compliance of salt restriction in Japanese hypertensive patients. Hypertens Res 2005;28:953–7
   PubMed Web of Science ®Google Scholar
• Weinberger MH, White WB, Ruilope LM, et al. Effects of eplerenone versus losartan in patients with low-renin hypertension. Am Heart J 2005;150:426–33
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009;53:982–92
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:413–19
   Web of Science ®Google Scholar
• Tsuchihashi T, Kai H, Kusaka M, et al. Report of the Salt Reduction Committee of the Japanese Society of Hypertension: (3) assessment and application of salt intake in the management of hypertension. Hypertens Res 2013;36:1026–31
   PubMed Web of Science ®Google Scholar
• The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2000;283:1967–75
   PubMed Web of Science ®Google Scholar
• Hood SJ, Taylor KP, Ashby MJ, Brown MJ. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Circulation 2007;116:268–75
   PubMed Web of Science ®Google Scholar
• Zillich AJ, Garg J, Basu S, Bakins GL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006;48:219–24
   PubMed Web of Science ®Google Scholar
• Flack JM, Oparil S, Pratt JH, et al. Efficacy and tolerability of eplerenone and losartan in black and white patients. Am J Coll Cardiol 2003;41:1148–55
   PubMed Web of Science ®Google Scholar
• Skalska A, Gasowski J, Stepniewski M, Grodzicki T. Antioxidative protection in hypertensive patients treated with diuretics. Am J Hypertens 2005;18:1130–2
   PubMed Web of Science ®Google Scholar
• Hwang MH, Yoo JK, Luttrell M, et al. Role of mineralocorticoid receptors in arterial stiffness in human aging. Exp Gerontol 2013;48:701–4
   PubMed Web of Science ®Google Scholar
• Chen H, Sun F, Zhong X, et al. Eplerenone-mediated aldosterone blockade prevents renal fibrosis by reducing renal inflammation, interstitial cell proliferation and oxidative stress. Kidney Blood Press Res 2013;37:557–66
   PubMed Web of Science ®Google Scholar
• Onozato ML, Tojo A, Kobayashi N, et al. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-β and NADPH oxidase in the hypertensive kidney. Nephrol Dial Transplant 2007;22:1314–22
   PubMed Web of Science ®Google Scholar
• Nishizaka M, Zaman MA, Sharon A, et al. Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism. Circulation 2004;109:2857–61
   PubMed Web of Science ®Google Scholar
• Bomback AS, Kshirsagar AV, Amamoo MA, Klemmer PJ. Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review. Am J Kiney Dis 2008;51:199–211
   PubMed Web of Science ®Google Scholar
• McMahon EG. Recent studies with eplerenone, a novel selective aldosterone receptor antagonist. Curr Opin Pharmacol 2001;1:190–6
   PubMedGoogle Scholar
• Uzu T, Kimura G. Diuretics shift circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation 1999;12:1635–8
   Google Scholar
• Uzu T, Harada T, Namba T, et al. Thiazide diuretics enhance nocturnal blood pressure fall and reduce proteinuria in immunoglobulin A nephropathy treated with angiotensin II modulators. J Hypertens 2005;23:861–5
   PubMed Web of Science ®Google Scholar